Brief: ScPharmaceuticals Announces Launch, Commercial Availability Of FUROSCIX

Scpharmaceuticals

21/02/2023 13:21

Feb 21 (Reuters) - scPharmaceuticals Inc  SCPH.O :
    * SCPHARMACEUTICALS ANNOUNCES LAUNCH AND COMMERCIAL
AVAILABILITY
OF FUROSCIX® (FUROSEMIDE INJECTION)
    * SCPHARMACEUTICALS INC - FUROSCIX IS NOT INDICATED FOR USE
IN
EMERGENCY SITUATIONS OR IN PATIENTS WITH ACUTE PULMONARY EDEMA
    * SCPHARMACEUTICALS INC - FUROSCIX INFUSOR WILL DELIVER ONLY
AN
80-MG DOSE

Source text for Eikon:  ID:nGNX2ZWLmb 
Further company coverage:  SCPH.O 
 ((Reuters.Briefs@thomsonreuters.com;))